FUNDAMENTALS
EdgeFII/DII
AGARWALEYEDR Agarwals Health Care L
₹553.50+0.07%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
AGARWALEYENSE · EquityHealthcare

DR Agarwals Health Care L

ISIN
INE943P01029
Instrument key
NSE_EQ|INE943P01029
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹553.50+0.40 · +0.07%
Day rangecircuit ₹442.75 – ₹664.05
547.55
557.90

as of 21/11/2026, 2:55:00 pm

Open
₹549.60
Day high
₹557.90
Day low
₹547.55
Prev. close
₹553.10
Volume
86.1K
VWAP
₹554.30

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

1 week · 15-minute candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M1Y5YMAX
Change · 1W
+0.98%
548.15 → 553.50
Period high
₹558.50
19/11/2026
Period low
₹535.00
18/11/2026
From high
-0.90%
+3.46% from low
Avg volume
4.7K
5.89 L total
Candles
125
59 up / 63 down
20 Nov 2026O 552.95H 554.80L 552.00C 553.50Vol 6.6K
SMA 20SMA 50Averages need 50 candles before they begin
Candle data125 rows of open, high, low, close and volumeShowHide
20 Nov 2026552.95554.80552.00553.50+0.10%2.806.6K
20 Nov 2026553.20554.45552.50552.95-0.05%1.956.6K
20 Nov 2026553.15553.55551.95553.10-0.01%1.601.7K
20 Nov 2026552.50554.20552.50553.25+0.14%1.702.2K
20 Nov 2026551.75552.85551.50552.40+0.12%1.351.5K
20 Nov 2026550.60552.35550.30551.75+0.21%2.052.7K
20 Nov 2026549.80552.45549.45550.60+0.15%3.004.1K
20 Nov 2026552.25552.90548.60549.65-0.47%4.304.9K
20 Nov 2026552.60553.15552.10552.25-0.06%1.053.4K
20 Nov 2026552.75553.25552.50552.60-0.03%0.751.7K

Historical price and volume data · Showing 1–10 of 125

1 / 13

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

85.46
Company
85.46
Sector
39.99

Worse than sector by 114%

P/B

Price ÷ book value per share

7.85
Company
7.85
Sector
4.0

Worse than sector by 96%

ROA

Net income ÷ total assets

4.88%
Company
4.88%
Sector
10.51%

Worse than sector by 54%

ROE

Net income ÷ shareholders' equity

8.04%
Company
8.04%
Sector
17.51%

Worse than sector by 54%

ROCE

EBIT ÷ capital employed

10.12%
Company
10.12%
Sector
18.73%

Worse than sector by 46%

Quick Ratio

Liquid assets ÷ current liabilities

1.04
Company
1.04
Sector
2.72

Worse than sector by 62%

EV/EBITDA

Enterprise value ÷ EBITDA

26.89
Company
26.89
Sector
14.77

Worse than sector by 82%

04/Business

About the company

Sector: Healthcare

Dr. Agarwal's Health Care Ltd is an India-based company, which operates as a health care institution. The Company is engaged in running, owning and managing eye care hospitals, optical, pharmacies, etc. and related services. It provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells optical, contact lenses and accessories, and eye-care related pharmaceutical products. Its services include surgeries and consultations, diagnoses and non-surgical treatments. Its surgery services include cataract surgery, refractive surgery, and other surgery. Its consultations, diagnoses and non-surgical treatments offer doctor consultation services, diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment. It provides a range of glasses, lenses, contact lenses and frames at its facilities.

Sector market cap (INR)
₹17,561 Cr

reported in crore

Sector market cap (USD)
$1.95B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Standalone income statement

Quarterly figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Sep 2026
₹573 Cr
+7.95% vs Jun 2026
Net profit · Sep 2026
₹44 Cr
+8.66% vs Jun 2026
Operating margin
10.3%
was 10.1%
Revenue CAGR · 4p
18.8%
profit 45.7% · op 42.7%
Filed order
Revenue573531354342
Revenue growthreported8.0%49.9%3.5%—
Operating profit59531820
Operating profit growthreported10.9%190.4%-9.8%—
Operating marginderived10.3%10.1%5.2%6.0%
Net profit44401114
Net profit growthreported8.7%277.8%-24.6%—
Net marginderived7.6%7.5%3.0%4.1%
EPS — basic₹/share, annual——1.25—

Figures in ₹ crore. Margin rows are computed from the reported values.

Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
Filed order
Revenue1,2931,044835598
Other Income33544718
Total Revenue1,3271,098882615
Total Expenses1,2561,045828592
Profit Before Tax643945-6
Tax251721-37
Profit After Tax39222432
EPS - Basic1.250.740.901.34
EPS - Diluted1.250.730.901.34

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.

06/Balance sheet

Standalone balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹2,961 Cr
+4.39% YoY
Total liabilities
₹970 Cr
Net worth
₹1,991 Cr
Liabilities ÷ assets
32.8%
lower means a lighter balance sheet
Filed order
Total assets2,9612,8372,1871,388
Total liabilities970903960826
Net worthderived1,9911,9341,227562
Liabilities ÷ assetsderived32.8%31.8%43.9%59.5%
Asset growthderived4.4%29.7%57.6%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets2,6542,2101,5571,187
Current Assets307627630201
Total Assets2,9612,8372,1871,388
Current Liabilities309342277213
Net Current Asset-2285353-13
Non-Current Liabilities661561683613
Equity Capital1,9911,9341,227562
Total Equity & Liabilities2,9612,8372,1871,388

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Standalone cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹321 Cr
+55.91% YoY
Investing
-₹167 Cr
Financing
-₹173 Cr
Free cash flow
₹154 Cr
operating + investing
Filed order
Operating activities321206222153
Operating changereported55.9%-7.2%45.1%—
Investing activities-167-577-818-436
Investing changereported71.1%29.4%-87.7%—
Financing activities-173374570316
Financing changereported-146.1%-34.4%80.5%—
Net cash flowderived-192-2633
Free cash flowoperating + investing154-372-596-283

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax643945-6
Income before WC changes332266233169
Change in Assets-6-90-33-13
Change in Liabilities2724349
Change in WC21-662-4
Cash flow from Operations321206222153
Cash flow from Investing-167-577-818-436
Cash flow from Financing-173374570316
Total Cash Flow-192-2633
Cash (Start of the year)54517744
Cash (End of the year)35545177

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
32.33%
-0.01 pts QoQ
FII
49.56%
-8.40 pts QoQ
DII (other)
1.69%
-0.01 pts QoQ
Mutual funds
14.18%
+8.16 pts QoQ
Retail & others
2.24%
+0.26 pts QoQ
Filed order
Promoters32.3%32.3%32.4%32.4%
FII49.6%58.0%57.9%58.1%
DII (other)1.7%1.7%2.0%2.0%
Mutual funds14.2%6.0%5.9%5.8%
Retail & others2.2%2.0%1.9%1.8%
Promoters — QoQ changepts, derived-0.0%-0.0%-0.0%—
FII — QoQ changepts, derived-8.4%0.0%-0.1%—
DII (other) — QoQ changepts, derived-0.0%-0.3%-0.0%—
Mutual funds — QoQ changepts, derived8.2%0.1%0.1%—
Retail & others — QoQ changepts, derived0.3%0.1%0.1%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

No corporate actions on record

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
FORTISFortis Healthcare LtdHealthcare Services₹825.00+1.87%22.88 L₹62,284 Cr$6.92B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

No news in the last seven days

Company news is available for a rolling one-week window.